258 related articles for article (PubMed ID: 29883054)
1. Genetic compensation of RUNX family transcription factors in leukemia.
Kamikubo Y
Cancer Sci; 2018 Aug; 109(8):2358-2363. PubMed ID: 29883054
[TBL] [Abstract][Full Text] [Related]
2. CROX (Cluster Regulation of RUNX) as a Potential Novel Therapeutic Approach.
Kamikubo Y
Mol Cells; 2020 Feb; 43(2):198-202. PubMed ID: 31991534
[TBL] [Abstract][Full Text] [Related]
3. Role of RUNX1 in hematological malignancies.
Sood R; Kamikubo Y; Liu P
Blood; 2017 Apr; 129(15):2070-2082. PubMed ID: 28179279
[TBL] [Abstract][Full Text] [Related]
4. Genetic regulation of the RUNX transcription factor family has antitumor effects.
Morita K; Suzuki K; Maeda S; Matsuo A; Mitsuda Y; Tokushige C; Kashiwazaki G; Taniguchi J; Maeda R; Noura M; Hirata M; Kataoka T; Yano A; Yamada Y; Kiyose H; Tokumasu M; Matsuo H; Tanaka S; Okuno Y; Muto M; Naka K; Ito K; Kitamura T; Kaneda Y; Liu PP; Bando T; Adachi S; Sugiyama H; Kamikubo Y
J Clin Invest; 2017 Jun; 127(7):2815-2828. PubMed ID: 28530640
[TBL] [Abstract][Full Text] [Related]
5. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
6. Structure and Biophysics of CBFβ/RUNX and Its Translocation Products.
Tahirov TH; Bushweller J
Adv Exp Med Biol; 2017; 962():21-31. PubMed ID: 28299648
[TBL] [Abstract][Full Text] [Related]
7. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.
Osato M
Oncogene; 2004 May; 23(24):4284-96. PubMed ID: 15156185
[TBL] [Abstract][Full Text] [Related]
8. A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells.
Oo ZM; Illendula A; Grembecka J; Schmidt C; Zhou Y; Esain V; Kwan W; Frost I; North TE; Rajewski RA; Speck NA; Bushweller JH
Leuk Lymphoma; 2018 Sep; 59(9):2188-2200. PubMed ID: 29249175
[TBL] [Abstract][Full Text] [Related]
9. The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.
Yokota A; Huo L; Lan F; Wu J; Huang G
Mol Cells; 2020 Feb; 43(2):145-152. PubMed ID: 31964134
[TBL] [Abstract][Full Text] [Related]
10. Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers.
Illendula A; Gilmour J; Grembecka J; Tirumala VSS; Boulton A; Kuntimaddi A; Schmidt C; Wang L; Pulikkan JA; Zong H; Parlak M; Kuscu C; Pickin A; Zhou Y; Gao Y; Mishra L; Adli M; Castilla LH; Rajewski RA; Janes KA; Guzman ML; Bonifer C; Bushweller JH
EBioMedicine; 2016 Jun; 8():117-131. PubMed ID: 27428424
[TBL] [Abstract][Full Text] [Related]
11. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.
Ito Y
Adv Cancer Res; 2008; 99():33-76. PubMed ID: 18037406
[TBL] [Abstract][Full Text] [Related]
12. Runx1/AML1 in normal and abnormal hematopoiesis.
Yamagata T; Maki K; Mitani K
Int J Hematol; 2005 Jul; 82(1):1-8. PubMed ID: 16105753
[TBL] [Abstract][Full Text] [Related]
13. Covalent Modifications of RUNX Proteins: Structure Affects Function.
Blumenthal E; Greenblatt S; Huang G; Ando K; Xu Y; Nimer SD
Adv Exp Med Biol; 2017; 962():33-44. PubMed ID: 28299649
[TBL] [Abstract][Full Text] [Related]
14. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis.
Bras S; Martin-Lannerée S; Gobert V; Augé B; Breig O; Sanial M; Yamaguchi M; Haenlin M; Plessis A; Waltzer L
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4986-91. PubMed ID: 22411814
[TBL] [Abstract][Full Text] [Related]
15. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
Bäckström S; Wolf-Watz M; Grundström C; Härd T; Grundström T; Sauer UH
J Mol Biol; 2002 Sep; 322(2):259-72. PubMed ID: 12217689
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and preliminary studies of the DNA-binding runt domain of AML1.
Bäckström S; Huang SH; Wolf-Watz M; Xie XQ; Härd T; Grundström T; Sauer UH
Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):269-71. PubMed ID: 11173476
[TBL] [Abstract][Full Text] [Related]
17. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
Okumura AJ; Peterson LF; Lo MC; Zhang DE
Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
[TBL] [Abstract][Full Text] [Related]
18. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic potential of the RUNX gene family: 'overview'.
Ito Y
Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
[TBL] [Abstract][Full Text] [Related]
20. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]